These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4400530)

  • 1. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
    Cuthbert MF; Owusu-Ankomah K
    Br J Pharmacol; 1971 Nov; 43(3):639-48. PubMed ID: 4400530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.
    Brick I; Hutchison KJ; McDevitt DG; Roddie IC; Shanks RG
    Br J Pharmacol; 1968 Sep; 34(1):127-40. PubMed ID: 4877600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K; Köhler E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):79-86. PubMed ID: 4397216
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
    Gibbons DO; Lant AF; Ashford A; Collins RF; Pinder S
    Br J Clin Pharmacol; 1976 Feb; 3(1):177-84. PubMed ID: 973938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between isoprenaline infusions and bolus injections to assess beta-adrenoceptor function in man, with special reference to cardiac contractility and the influence of autonomic reflexes.
    Martinsson A; Melcher A; Lindvall K; Hjemdahl P
    Acta Physiol Scand; 1991 Feb; 141(2):167-80. PubMed ID: 1646559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of M & B 17803A in man.
    Leary WP; Coleman AJ
    S Afr Med J; 1972 Aug; 46(34):1202-3. PubMed ID: 4403479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.